Literature DB >> 33632179

Human papillomavirus infection rate, distribution characteristics, and risk of age in pre- and postmenopausal women.

Yan Shen1, Jing Xia1, Huihui Li1, Yang Xu1, Sanping Xu2.   

Abstract

BACKGROUND: The incidence rate of cervical cancer is increasing yearly. The persistent infection of high-risk human papillomavirus (HPV) is the main factor leading to cervical cancer. HPV infection is double peak type. This study aimed at analyzing the HPV distribution characteristics, infection rate, and risk of age in pre- and postmenopausal women. So as to provide reference for the prevention of HPV infection and cervical cancer screening strategy.
METHODS: A retrospective analysis of 4614 women who underwent cervical cytology, and HPV examination from January 2018 to October 2019 at the healthcare department of Wuhan Union Hospital was done. We explored the characteristics and distribution of HPV infections around the menopause, then comparing the infection rate of HPV in postmenopause and over 65 years old, in order to analyze the influence of different ages on HPV infection.
RESULTS: Generally, the HPV infection rate was 13.10% (539/4115), whereby the high-risk subtype constituted 73.84% (398/539) of all positive cases. On the other hand, the HPV39 infection was more common in postmenopausal women; however, there was no significant difference in the distribution of the other types in the pre- and postmenopausal women. The first four types were 52/53/58/16. The results further showed that the rates of HPV infection before and after menopause were 12.34% (367/2975) and 15.09% (172/1140), respectively, which had no significant difference (P = 0.056), but more susceptible to high-risk HPV infection after the age of 65 (P = 0.041). Except for 40 years old to menopause, the infection rate of high-risk HPV in this age group was different from that in postmenopause (P = 0.023, 0.729 (0.555, 0.957)), other age groups had no significant effect on high-risk HPV infection.
CONCLUSIONS: It was concluded that whether menopause has nothing to do with HPV infection. Moreover, the risk of high-risk HPV infection in women aged 40 to premenopausal is relatively low, but the infection rate increases after 65. Hence the cutoff screening age should be appropriately prolonged.

Entities:  

Keywords:  Cervical cancer screening; Menopausal women; Papillomavirus infection

Mesh:

Year:  2021        PMID: 33632179      PMCID: PMC7905912          DOI: 10.1186/s12905-021-01217-4

Source DB:  PubMed          Journal:  BMC Womens Health        ISSN: 1472-6874            Impact factor:   2.809


  20 in total

Review 1.  The Pap Test and Bethesda 2014. "The reports of my demise have been greatly exaggerated." (after a quotation from Mark Twain).

Authors:  Ritu Nayar; David C Wilbur
Journal:  Acta Cytol       Date:  2015-05-19       Impact factor: 2.319

2.  Results of a phase II randomized, double-blind, placebo-controlled trial of Polyphenon E in women with persistent high-risk HPV infection and low-grade cervical intraepithelial neoplasia.

Authors:  Francisco A R Garcia; Terri Cornelison; Tomas Nuño; David L Greenspan; John W Byron; Chiu-Hsieh Hsu; David S Alberts; H-H Sherry Chow
Journal:  Gynecol Oncol       Date:  2014-01-02       Impact factor: 5.482

Review 3.  Role of cervical screening in older women.

Authors:  Laurie Elit
Journal:  Maturitas       Date:  2014-10-02       Impact factor: 4.342

4.  [Relationship of HPV infection and BV, VVC, TV: a clinical study based on 1 261 cases of gynecologic outpatients].

Authors:  L T Meng; Y Xue; T Yue; L Yang; L Gao; R F An
Journal:  Zhonghua Fu Chan Ke Za Zhi       Date:  2016-10-25

5.  Evaluation of multiple primary and combination screening strategies in postmenopausal women for detection of cervical cancer in China.

Authors:  Hunter K Holt; Li Zhang; Fang-Hui Zhao; Shang-Ying Hu; Xue-Lian Zhao; Xun Zhang; Qin-Jing Pan; Wen-Hua Zhang; Jennifer S Smith; You-Lin Qiao
Journal:  Int J Cancer       Date:  2016-10-31       Impact factor: 7.396

6.  Screening for Cervical Cancer: US Preventive Services Task Force Recommendation Statement.

Authors:  Susan J Curry; Alex H Krist; Douglas K Owens; Michael J Barry; Aaron B Caughey; Karina W Davidson; Chyke A Doubeni; John W Epling; Alex R Kemper; Martha Kubik; C Seth Landefeld; Carol M Mangione; Maureen G Phipps; Michael Silverstein; Melissa A Simon; Chien-Wen Tseng; John B Wong
Journal:  JAMA       Date:  2018-08-21       Impact factor: 56.272

7.  Interplay between the temporal dynamics of the vaginal microbiota and human papillomavirus detection.

Authors:  Rebecca M Brotman; Michelle D Shardell; Pawel Gajer; J Kathleen Tracy; Jonathan M Zenilman; Jacques Ravel; Patti E Gravitt
Journal:  J Infect Dis       Date:  2014-06-18       Impact factor: 5.226

8.  Cervical screening at age 50-64 years and the risk of cervical cancer at age 65 years and older: population-based case control study.

Authors:  Alejandra Castañón; Rebecca Landy; Jack Cuzick; Peter Sasieni
Journal:  PLoS Med       Date:  2014-01-14       Impact factor: 11.069

9.  Cervical intraepithelial neoplasia disease progression is associated with increased vaginal microbiome diversity.

Authors:  A Mitra; D A MacIntyre; Y S Lee; A Smith; J R Marchesi; B Lehne; R Bhatia; D Lyons; E Paraskevaidis; J V Li; E Holmes; J K Nicholson; P R Bennett; M Kyrgiou
Journal:  Sci Rep       Date:  2015-11-17       Impact factor: 4.379

Review 10.  Educational Interventions for Cervical Cancer Screening Behavior of Women: A Systematic Review

Authors:  Marzieh Saei Ghare Naz; Nourossadat Kariman; Abbas Ebadi; Giti Ozgoli; Vida Ghasemi; Farzaneh Rashidi Fakari
Journal:  Asian Pac J Cancer Prev       Date:  2018-04-25
View more
  3 in total

1.  Meta-synthesis and science mapping analysis of HIV/HPV co-infection: a global perspective with emphasis on Africa.

Authors:  Hope Onohuean; Eric O Aigbogun; Bright E Igere
Journal:  Global Health       Date:  2022-03-24       Impact factor: 4.185

2.  Diagnostic value of colposcopy in patients with cytology-negative and HR-HPV-positive cervical lesions.

Authors:  Yang Liu; Jing Liao; Xiaojia Yi; Zhengmei Pan; Jing Pan; Chunyi Sun; Honglin Zhou; Yushi Meng
Journal:  Arch Gynecol Obstet       Date:  2022-03-23       Impact factor: 2.493

Review 3.  Human Papilloma Virus Vaccination.

Authors:  Kendal Rosalik; Christopher Tarney; Jasmine Han
Journal:  Viruses       Date:  2021-06-08       Impact factor: 5.048

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.